Cargando…

Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors

In this paper, both methods (DFT and HF) were used in a theoretical investigation of 3-bromo-2-Hydroxypyridine (3-Br-2HyP) molecules where the molecular structures of the title compound have been optimized. Molecular electrostatic potential (MEP) was computed using the B3LYP/6-311++G(d,p) level of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefi, Nizar, Kazachenko, Aleksandr S., Raja, Murugesan, Issaoui, Noureddine, Kazachenko, Anna S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054851/
https://www.ncbi.nlm.nih.gov/pubmed/36985641
http://dx.doi.org/10.3390/molecules28062669
_version_ 1785015771494088704
author Lefi, Nizar
Kazachenko, Aleksandr S.
Raja, Murugesan
Issaoui, Noureddine
Kazachenko, Anna S.
author_facet Lefi, Nizar
Kazachenko, Aleksandr S.
Raja, Murugesan
Issaoui, Noureddine
Kazachenko, Anna S.
author_sort Lefi, Nizar
collection PubMed
description In this paper, both methods (DFT and HF) were used in a theoretical investigation of 3-bromo-2-Hydroxypyridine (3-Br-2HyP) molecules where the molecular structures of the title compound have been optimized. Molecular electrostatic potential (MEP) was computed using the B3LYP/6-311++G(d,p) level of theory. The time-dependent density functional theory (TD-DFT) approach was used to simulate the HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) on the one hand to achieve the frontier orbital gap and on the other hand to calculate the UV–visible spectrum of the compound in gas phase and for different solvents. In addition, electronic localization function and Fukui functions were carried out. Intermolecular interactions were discussed by the topological AIM (atoms in molecules) approach. The thermodynamic functions have been reported with the help of spectroscopic data using statistical methods revealing the correlations between these functions and temperature. To describe the non-covalent interactions, the reduced density gradient (RDG) analysis is performed. To study the biological activity of the compound of the molecule, molecular docking studies were executed on the active sites of BRD2 inhibitors and to explore the hydrogen bond interaction, minimum binding energies with targeted receptors such as PDB ID: 5IBN, 3U5K, 6CD5 were calculated.
format Online
Article
Text
id pubmed-10054851
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100548512023-03-30 Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors Lefi, Nizar Kazachenko, Aleksandr S. Raja, Murugesan Issaoui, Noureddine Kazachenko, Anna S. Molecules Article In this paper, both methods (DFT and HF) were used in a theoretical investigation of 3-bromo-2-Hydroxypyridine (3-Br-2HyP) molecules where the molecular structures of the title compound have been optimized. Molecular electrostatic potential (MEP) was computed using the B3LYP/6-311++G(d,p) level of theory. The time-dependent density functional theory (TD-DFT) approach was used to simulate the HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) on the one hand to achieve the frontier orbital gap and on the other hand to calculate the UV–visible spectrum of the compound in gas phase and for different solvents. In addition, electronic localization function and Fukui functions were carried out. Intermolecular interactions were discussed by the topological AIM (atoms in molecules) approach. The thermodynamic functions have been reported with the help of spectroscopic data using statistical methods revealing the correlations between these functions and temperature. To describe the non-covalent interactions, the reduced density gradient (RDG) analysis is performed. To study the biological activity of the compound of the molecule, molecular docking studies were executed on the active sites of BRD2 inhibitors and to explore the hydrogen bond interaction, minimum binding energies with targeted receptors such as PDB ID: 5IBN, 3U5K, 6CD5 were calculated. MDPI 2023-03-15 /pmc/articles/PMC10054851/ /pubmed/36985641 http://dx.doi.org/10.3390/molecules28062669 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lefi, Nizar
Kazachenko, Aleksandr S.
Raja, Murugesan
Issaoui, Noureddine
Kazachenko, Anna S.
Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title_full Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title_fullStr Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title_full_unstemmed Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title_short Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors
title_sort molecular structure, spectral analysis, molecular docking and physicochemical studies of 3-bromo-2-hydroxypyridine monomer and dimer as bromodomain inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054851/
https://www.ncbi.nlm.nih.gov/pubmed/36985641
http://dx.doi.org/10.3390/molecules28062669
work_keys_str_mv AT lefinizar molecularstructurespectralanalysismoleculardockingandphysicochemicalstudiesof3bromo2hydroxypyridinemonomeranddimerasbromodomaininhibitors
AT kazachenkoaleksandrs molecularstructurespectralanalysismoleculardockingandphysicochemicalstudiesof3bromo2hydroxypyridinemonomeranddimerasbromodomaininhibitors
AT rajamurugesan molecularstructurespectralanalysismoleculardockingandphysicochemicalstudiesof3bromo2hydroxypyridinemonomeranddimerasbromodomaininhibitors
AT issaouinoureddine molecularstructurespectralanalysismoleculardockingandphysicochemicalstudiesof3bromo2hydroxypyridinemonomeranddimerasbromodomaininhibitors
AT kazachenkoannas molecularstructurespectralanalysismoleculardockingandphysicochemicalstudiesof3bromo2hydroxypyridinemonomeranddimerasbromodomaininhibitors